Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Xilio Therapeutics (XLO) Other Gross PP&E Adjustments (2024 - 2025)

Xilio Therapeutics' Other Gross PP&E Adjustments history spans 2 years, with the latest figure at $6.8 million for Q3 2025.

  • For Q3 2025, Other Gross PP&E Adjustments rose 13.13% year-over-year to $6.8 million; the TTM value through Sep 2025 reached $6.8 million, up 13.13%, while the annual FY2024 figure was $6.6 million, N/A changed from the prior year.
  • Other Gross PP&E Adjustments for Q3 2025 was $6.8 million at Xilio Therapeutics, down from $7.0 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $7.0 million in Q2 2025 and bottomed at $6.0 million in Q1 2024.